Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 02, 2015
Source ID
10.1007/s10549-015-3442-z

Entities

People

  • Amanda J. Schech
  • Angela Brodie
  • Armina Kazi
  • Gauri J. Sabnis
  • Olga Goloubeva
  • Paula Rosenblatt
  • Preeti Shah
  • Saranya Chumsri
  • Stephen Yu

Organizations

  • National Cancer Institute
  • Susan G. Komen for the Cure
  • United States Department of Defense